Drugs / Lu AF88434
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04538014 | Aug → Oct 2020 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT04082325 | Jul 2019 → Sep 2020 | — | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF88434 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04082325 ↗ |
| Route | Oral | “Lu AF88434, single oral solution” NCT04082325 ↗ |